Related Experiment Videos
Mast cells in pulmonary haemosiderosis
Archives of Disease in Childhood
|March 1, 1984
Summary
Childhood pulmonary haemosiderosis was linked to increased lung mast cells. Disodium cromoglycate may be a beneficial treatment for this rare pediatric lung disease.
Area of Science:
- Pulmonary Medicine
- Pediatric Pathology
- Immunology
Background:
- Pulmonary haemosiderosis is a rare lung disease characterized by recurrent pulmonary hemorrhage.
- Mast cells play a role in inflammatory and allergic responses within the respiratory system.
Observation:
- A pediatric case of pulmonary haemosiderosis exhibited a significant fourfold increase in lung mast cells compared to controls.
- This observation suggests a potential link between mast cell degranulation and the pathogenesis of the disease.
Findings:
- The study describes a unique case of childhood pulmonary haemosiderosis.
- A marked elevation in pulmonary mast cell counts was a key finding in this patient.
- The role of these mast cells in the disease's development is explored.
Implications:
- Increased mast cell activity may contribute to the pathogenesis of pulmonary haemosiderosis.
- Disodium cromoglycate, a mast cell stabilizer, is proposed as a potential therapeutic agent.
- Further research into mast cell involvement could lead to novel treatment strategies for pediatric lung diseases.